partnership

U-Factor Holdings Decides to Adopt Toyota's "WAVEBASE" for Drug Discovery Research Using Stem Cell Conditioned Medium "U-Factor®"

Citation-Grade Primary-source linked Schema.org verified NQ 50 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Mar 31, 2026 7:00 PM ・ Updated Jun 17, 2026 10:02 AM ・ 7 min read ・ Source: PR TIMES

Show contents

⚡ Key Points

U-Factor Holdings has announced the adoption of Toyota Motor Corporation's data analysis system, "WAVEBASE," to enhance its drug discovery research.
By integrating protein data from its proprietary stem cell conditioned medium, "U-Factor®," the company aims to modernize its analytical framework, with implementation scheduled for April 2026.

U-Factor Holdings has announced the adoption of Toyota Motor Corporation's data analysis system, "WAVEBASE," to enhance its drug discovery research. By integrating protein data from its proprietary stem cell conditioned medium, "U-Factor®," the company aims to modernize its analytical framework, with implementation scheduled for April 2026.

PRIMARY SOURCE PR TIMES View source Distributor: PR TIMES
Published: Mar 31, 2026

U-Factor Holdings Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo; Representative Director: Hidehiro Ijima; hereinafter "the Company") has decided to adopt "WAVEBASE," a data analysis system provided by Toyota Motor Corporation (Headquarters: Toyota City, Aichi Prefecture; President and CEO: Koji Sato; hereinafter "Toyota"). The Company will utilize cross-sectional data, including protein data from stem cell conditioned medium, to modernize its analytical framework for drug discovery research.

Preparations for implementation, including requirements definition and environment design, have begun with a target launch date of April 2026.

1. Key Points of this Release - Decision to adopt "WAVEBASE" to strengthen the analytical foundation for drug discovery research using stem cell conditioned medium. - Establishment of an integrated analytical framework targeting protein data and other information from stem cell conditioned medium. - Implementation scheduled to begin around April 2026.

2. Background Drug discovery research involving stem cell conditioned medium requires the handling of diverse data across various domains. The Company has been considering the strengthening of its analytical foundation, identifying the management of research data and the development of analytical processes as critical issues.

3. Initiatives (Roles of each company) - The Company: Design of data integration and analytical operations for drug discovery research; utilization in research and development. - Toyota: Provision of the "WAVEBASE" data analysis system and technical support.

4. Future Schedule - Scheduled implementation: April 2026 *The contract conclusion and implementation timing are subject to change based on future discussions and procedures.

5. About "WAVEBASE" "WAVEBASE" is a cloud-based data analysis service provided by Toyota. The Company decided to adopt it for the purpose of supporting analytical tasks involving the diverse data generated in its research and development activities. WAVEBASE | TOYOTA: https://www.toyota.co.jp/wavebase/

6. About our proprietary stem cell conditioned medium "U-Factor®" We have named our high-purity stem cell conditioned medium "U-Factor®" (Registration No. 6396893), which is purified using our proprietary technology from the supernatant obtained during the stem cell culture process. It contains a large amount of cytokines (proteins with physiological activity) secreted by stem cells. We believe that U-Factor®, purified through specialized methods and continuous improvement, holds significant potential regarding safety and efficacy.

7. Company Overview U-Factor Holdings Co., Ltd. Address: 6-4-6 Kojimachi, Chiyoda-ku, Tokyo 102-0083 Representative: Hidehiro Ijima, Representative Director Established: February 4, 2026 Business Description: Formulation of management strategy and management administration for the entire group https://u-factor.com

Toyota Motor Corporation Address: 1 Toyota-cho, Toyota City, Aichi Prefecture 471-8571 Representative: Koji Sato, President and CEO Established: August 28, 1937 Business Description: Production and sales of automobiles https://global.toyota/jp/

[Inquiries regarding this release] U-Factor Holdings Co., Ltd. Public Relations TEL: 03-5357-1580 Email: info@u-factor.com

FACT BOX

Source: PR TIMES
Category: partnership

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Mar 31, 2026 7:00 PM — Distributor PR TIMES
Collected　Apr 1, 2026 1:39 PM
AI structured & analyzed　Jun 2, 2026 1:02 PM
Desk-reviewed & published　Mar 31, 2026 7:00 PM

FAQ

What company has decided to adopt Toyota's WAVEBASE for drug discovery research using stem cell conditioned medium?

U-Factor Holdings Co., Ltd., headquartered in Chiyoda-ku, Tokyo, has decided to adopt Toyota's WAVEBASE for drug discovery research using its stem cell conditioned medium product U-Factor®.

What is the name of the data analysis system provided by Toyota that U-Factor Holdings will adopt?

The data analysis system provided by Toyota that U-Factor Holdings will adopt is called WAVEBASE, a cloud-based platform designed for advanced data integration and analysis.

What type of data will U-Factor Holdings integrate using the WAVEBASE system in its drug discovery research?

U-Factor Holdings will integrate cross-sectional data, including protein data and other information from stem cell conditioned medium, using Toyota's WAVEBASE system in its drug discovery research.

When is the scheduled implementation date for U-Factor Holdings to begin using the WAVEBASE system?

The scheduled implementation date for U-Factor Holdings to begin using the WAVEBASE system is around April 2026, pending final discussions and contractual procedures.

What roles will Toyota and U-Factor Holdings play in the implementation of the WAVEBASE system?

Toyota will provide the WAVEBASE data analysis system and technical support, while U-Factor Holdings will design data integration processes and use the system in its drug discovery research and development.

Cite this article — HOW TO CITE

Washin AI News Desk“U-Factor Holdings Decides to Adopt Toyota's "WAVEBASE" for Drug Discovery Research Using Stem Cell Conditioned Medium "U-Factor®"”AI News by Washin Village（和心村）, Mar 31, 2026. https://aeo.washinmura.jp/ai/u-factor-com/en/news/2026-04-20-news-oig629

AI CRAWLER ACTIVITY

as of Jun 30, 2026

AI crawler visits to this article (cumulative)Measuring since publication (no visits recorded yet)

Site-wide cumulative

ClaudeBot

bot_visits_summary

4372k

last Jun 30, 2026

GPTBot

bot_visits_summary

2885k

last Jun 30, 2026

Google AI

bot_visits_summary

1788k

last Jun 30, 2026

Bingbot

bot_visits_summary

1750k

last Jun 30, 2026

Googlebot

bot_visits_summary

1301k

last Jun 30, 2026

Meta AI

bot_visits_summary

619k

last Jun 30, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← u-factor-com Back to newsroom (40)